Clinical Trial Update: A Study to Assess the Efficacy and Safety of Burfiralimab(hzVSF-v13) and OAD (Oral Antiviral Drug) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Burfiralimab in combination with an Oral Antiviral Drug for chronic hepatitis B; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Burfiralimab (Burfiralimab)
• Oral Antiviral Drug

Snippet

Sponsor: ImmuneMed, Inc. | Conditions: Chronic Hepatitis B | Phase 2 | Status: UNKNOWN